Tuesday, January 29, 2013 - Thursday, January 31, 2013
This U.S. FDA co-sponsored WCBP Symposium series is the pre-eminent conference addressing the analytical development/regulatory control interface for biotechnology derived health intervention products. The goal of this Symposium series is to provide a forum for discussing the latest bioanalytical methods and their practical application to biotechnology pharmaceuticals and other health related products. Both state-of-the-art innovations as well as conventional technologies addressing research and routine testing applications will be covered. This includes both method and instrumental advances that are used for product characterization, process development, in-process analysis and validate release & stability testing.
WCBP 2013 is co-sponsored by CASSS and the United States Food & Drug Administration (FDA).
1127 Connecticut Avenue, NW
Washington, DC 20036 United States
CASSS - An International Separation Science Society | 5900 Hollis Street, Suite R3 Emeryville, CA 94608 | Ph: 510.428.0740 | Fax: 510.428.0741